| Literature DB >> 36006212 |
Pierre Bouteiller1,2, Emilie Lance1,3, Thierry Guérin4, Ronel Biré2.
Abstract
Microcystins (MCs) are cyclic heptapeptidic toxins produced by many cyanobacteria. Microcystins can be accumulated in various matrices in two forms: a free cellular fraction and a covalently protein-bound form. To detect and quantify the concentration of microcystins, a panel of techniques on various matrices (water, sediments, and animal tissues) is available. The analysis of MCs can concern the free or the total (free plus covalently bound) fractions. Free-form analyses of MCs are the most common and easiest to detect, whereas total-form analyses are much less frequent and more complex to achieve. The objective of this review is to summarize the different methods of extraction and analysis that have been developed for total forms. Four extraction methods were identified: MMPB (2-methyl-3-methoxy-4-phenylbutyric acid) method, deconjugation at basic pH, ozonolysis, and laser irradiation desorption. The study of the bibliography on the methods of extraction and analysis of the total forms of MCs showed that the reference method for the subject remains the MMPB method even if alternative methods and, in particular, deconjugation at basic pH, showed results encouraging the continuation of the methodological development on different matrices and on naturally-contaminated samples.Entities:
Keywords: MMPB method; cyanotoxins; deconjugation at basic pH; laser irradiation desorption; method of analysis; microcystins; ozonolysis; total toxins content
Mesh:
Substances:
Year: 2022 PMID: 36006212 PMCID: PMC9416067 DOI: 10.3390/toxins14080550
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Figure 1Topological representation of an MC with 1: D-Alanine, 2: X (variable), 3: D-erythro-b-methyl-D-aspartic acid, 4: Z (variable), 5: Adda, 6: D-Glutamate, 7: Mdha. The Adda fragment is a common part of all MC variants and nodularins, another cyanotoxins. The Mdha fragment plays a role in the binding of MCs to proteins. The variable amino acids (X and Z) as well as the possibility of substitution on 1, 3, 5, 6, 7 will define the identity of the MCs variant and participates in the diversity of the MCs. 279 MCs congeners have been listed in Bouaïcha et al. [9].
Figure 2Structure of microcystin-LR (MC-LR) with its specific Adda moiety subject to Lemieux oxidation resulting in MMPB production (modified after Suchy and Berry [61]).
A comparison of the various conditions of the MMPB method protocols in scientific publications (modified after Anaraki et al. [87]). (n.s.: not specified; dw: dry weight).
| References | Matrix | Quantity of Matrices | Pre-Treatment Step | Oxidation Length (Hour) | [KMnO4] | [NaIO3] or [NaIO4] | pH | End of Reaction | Purification Method | Detection Limits | Instrumental Analysis | Yield | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sano et al. [ | MC fraction from waterblooms ( | 0.2–1 mg (dw) | - | 4 | 0.024 M | 0.02 M | n.s. | 0.04 mL of 20% NaHSO₃ + 0.01 mL of 1OM H2SO4 | 5 mL of ethyl acetate | pmol | GC-FID/HPLC | 84–98% | |
| Williams et al. [ | Salmon Liver ( | 220–1366 mg | - | overnight | 36.1 µM | 1.3852 mM | 9 (120.8 µM of K2CO3) | NaHSO₃ + 10% H2SO4 (pH~2) | Diethyl ether | 15 µg/g | GC/MS | 85–95% | |
| Dungeness Crab Larvae ( | 5.2–5.4 g | n.s. | |||||||||||
| Williams et al. [ | Saltwater mussels, ( | 5.5–8.3 g | - | n.s. | 334.2 µM | 12.3 mM | 9 | NaHSO₃ + 10% H2SO4 (pH ≈ 1–2 | Diethyl ether | 15 µg/g | GC/MS | n.s. | |
| Pires et al. [ | Zebra mussels ( | Pooled mussel material | - | overnight | 0.1 M | 0.4 M | 9 | H2SO4 (1 M), pH < 3 | C18 (Supelco) | n.s. | LC/MS | n.s. | |
| Ott and Carmichael [ | Rat or chicken livers (species n.s.) | 0.5–1 g | - | 3 | 0.02 M | 0.02 M | 9 (KHCO3) | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | 3 M Empore SDB-XC 7 mm/3 mL (Fischer Scientific, Hampton, NH, USA) | 5 µg/g | LC/MS | 33.5% | |
| Soares et al. [ | Human sera | 0.4–1 mL | - | 3 | 0.02 M | 0.02 M | 9 (KHCO3) | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | 3 M Empore SDB-XC 7 mm/3 mL (Fischer Scientific) | n.s | LC/MS | n.s. | |
| Yuan et al. [ | Human Liver/sera | n.s. | - | 3 | 0.02 M | 0.02 M | 9 (KHCO3) | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | 3 M Empore SDB-XC 7 mm/3 mL (Fischer Scientific) | n.s. | GC/MS | n.s. | |
| Hilborn et al. [ | Human blood | n.s. | - | 3 | 0.02 M | 0.02 M | 9 (KHCO3) | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | 3M Empore SDB-XC 7 mm/3 mL (Fischer Scientific) | n.s | LC/MS | n.s. | |
| Nasri et al. [ | Terrapin ( | 100 mg (dw) | - | 3 | 0.02 M | 0.02 M | 9 (KHCO3) | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | Conversion of MMPB to methyl ester using 12% trifluoroborate in MeOH | n.s. | GC/MS | n.s. | |
| Wu et al. [ | Aqueous solution spiked with MC-LR | - | - | hours | 50 mg/L | 20 mg/L | 1.6 | NaHSO₃ | - | n.s. | HPLC/DAD | ~90% | |
| Wu et al. [ | Cyanobacterial samples ( | 10; 20; 40; 60; 80; 100 mg (dw) | - | 1–4 | ≥0.05 M | 0.2 M | 9 (KHCO3) | Saturated NaHSO₃ sol. | - | n.s | LC/DAD | 86.7% | |
| Lance et al. [ | Tissues of snails ( | 10 mg (freeze-dried) | Trypsin in Sörensen’s phosphate buffer (0.5 mg/mL, pH 7.5, 37 °C) | 3 | 0.1 M | 0.1 M | 9 | 40% NaHSO₃ + 10% H2SO4 | Oasis HLB 30 mg | n.s. | LC/MS | 16–37% | |
| Suchy and Berry [ | Rainbow Trout ( | 1 mL of liver slurry | - | 3 | 0.0035 M | 0.09 M | 9 | 0.5–1.5 g of NaHSO₃ + 10% H2SO4 (pH ≈ 2) | Solid phase microextraction (PDMS-DVB fibre) | 0.04 µg/g | GC/MS | n.s. | |
| Wu et al. [ | Lake sediment | 2 g (freeze dried) | - | 1–4 | 0.05 M | 0.1 M | 9 | Saturated NaHSO₃ sol. | Sep-pak C18 500 mg (Waters) | n.s. | HPLC/DAD | 33-45% | |
| Bieczynski et al. [ | Supernatants of liver and intestines from fish ( | 1 g | - | overnight | 0.002 M | 0.007 M | 9 | 20% NaHSO₃ + drops of 10% H2SO4 | Diethyl ether | 0.2 ng | GC/MS | 67.25 ± 26% | |
| Cadel-Six et al. [ | Rainbow trout ( | Liver | 60 mg 100 mg | Trypsin in Sörensen’s phosphate buffer (0.5 mg/mL, pH 7.5, 37 °C) | 4 | 0.1 M | 0.1 M | 9 | 40% NaHSO₃ + 10% H2SO4 (pH ≈ 1.5) | SampliQ OPT 150 mg (Agilent) | 2.59 ng/g | LC/MS | 17% |
| Roy-Lachapelle et al. [ | River water | n.s. | - | 1 | 0.05 M | 0.05 M | 9 (K2CO3) | 40% NaHSO₃ + 10% H2SO4 (pH ≈ 2) | Ethyl acetate | 0.2 µg/L | LDTD/APCI/MS | 91% | |
| Roy-Lachapelle et al. [ | Frozen homogenized fish tissue (( | 1 g | 3 freeze-thaw lysis cycles + 2 h in NaOH (50 mM) | 2 | 0.05 M | 0.05 M | 9 (HCl, 50 mM) | Saturated NaHSO₃ sol. + 10% H2SO4 (pH ≈ 2) | Filter the supernatants with 0.2 µM nylon filter (Whatman) + Strata SDB-L 500 mg (Phenomenex) | 2.7 ng/g | LDTD/APCI/HRMS | 54–72% | |
| Foss and Aubel [ | Raw and trated water from Ohio water sources | n.s. | 3 freeze-thaw cycles + 10/100x concentration (SPE) | 0.5 | 0.015 M | 0.015 M | n.s. | 40% NaHSO₃ + phosphate buffer to raise pH < 5 | Strata X 100 mg (Phenomenex) | 0.05 µg/L | LC/MS | n.s. | |
| Wang et al. [ | Water | 0.1 mL | - | 1 | 4 g/L | 20 mg/L | n.s. | 40% NaHSO₃ (50 µL: water/0.5 mL: sediment) | Sep-Pak cartridge (500 mg, 6 cm3) | 125 ng/L | HPLC/FLD | 98–109% | |
| Greer et al. [ | Tilapia ( | 50 mg (dw) | - | 2 | 0.1 M | 0.1 M | n.s. | 40% NaHSO₃ + 10% H2SO4 (pH ≈ 2) | Oasis PRiME 60 mg (Waters) | n.s. | UPLC/MS | 55% | |
| Munoz et al. [ | Surface Water | 10 mL | 3 freeze-thaw cycles + filtration (0.22 µM nylon filters) | 1 | 0.35 M | 0.4 M | 9 (K2CO3, 1 M) | NaHSO₃ (4 M) | Filtration (0.22 µM nylon filters) + on-line SPE | 0.5 ng/L | LC/MS | 65% | |
| Roy-Lachapelle et al. [ | Algary dietary supplements | 0.3 g | - | 2 | 0.05 M | 0.05 M | 9 (K2CO3) | Saturated NaHSO₃ sol. + 10% H2SO4 (pH ≈ 2) | Filtration (0.2 µM nylon filter, Whatman) + Strata SDB-L 500 mg (Phenomenex) | 0.2 µg/g | LDTD/APCI/HRMS | 67–74% | |
| Vudathala et al. [ | Liver and plasma from channel catfish ( | <0.5 g/0.08–0.18 g | - | 3 | 0.002 M | 0.002 M | 9 (Na2CO3, 1 M) | NaHSO₃ + 0.5 mL of concentrated H2SO4 (pH ≤ 2) | Filtration (0.2 µM nylon filter, Whatman) + Oasis HLB 60 mg (Waters) | 5.2–6.2 ng/g | LC/MS | 31%/21% | |
| Brown et al. [ | Bottlenose dolphins liver ( | n.s. | - | 2.5 | 0.1 M | 0.1 M | n.s. (K2CO3, 0.2 M) | 40% NaHSO₃ | Strata-X 200 mg (Phenomenex) | 1.3 µg/g (dw) | LC/MS | 39% | |
| Duncan et al. [ | Aqueous samples/Algal reference material suspensions | n.s./25 mg (dw) in 200 mL of water | - | 1.5 | 0.025 M | 0.009 M | 9 (KHCO3, 0.5 M) | 40% NaHSO₃ + HCl (6 M, pH ≈ 3) | Semi-permeable | 1 µg/L | CP/MIMS | n.s. | |
| Foss et al. [ | Mallard duck ( | 100 mg (dw) | - | 2 | 0.25 M | 0.25 M | KHCO3 (1 M) | 40% NaHSO₃ + 50% H2SO4 (pH < 2) | Ethyl acetate + Strata-X 200 mg (Phenomenex) | n.s. | LC/MS | n.s. | |
| Greer et al. [ | Porcine tissue | 50 mg (dw) | - | 2 | 0.1 M | 0.2 M | n.s. | 40% NaHSO3 + 10% H2SO4 | Oasis PRiME HLB (Waters) | n.s. | UPLC/MS | 83% | |
| Foss et al. [ | Dogs ( | Liver | 100 mg | - | 2 | 0.1 M | 0.1 M | (K2CO3, 0.2 M) | 40% NaHSO₃ | Strata-X 200 mg (Phenomenex) + filtration (PVDF; 0.2 µM; Sigma) | 4 ng/g | LC/MS | 21% |
| Mohamed et al. [ | Nile tilapia | n.s. | As described in Neffling et al. [ | n-hexane | n.s. | LC/DAD | n.s. | ||||||
| Anaraki et al. [ | Rainbow Trout | 100 mg (dw) | - | 2 | 0.3 mM | 0.02 M | 8.5 | NaHSO₃ + 10% H2SO4 (pH = 3) | Oasis HLB 400 mg (Waters) + Pall GHP filters | 7.28 ng/g | LC/MS | 30% | |
| Bolotaolo et al. [ | Sediments/clams | 1/0.1 g (dw) | - | 3 | 0.1 M | 0.1 M | 9 | NaHSO₃ (1–1.5 g) + 10% H2SO4 (pH = 2) | ENV-Bond Elut 100 mg (Agilent) + esterification | 10/15 ng/g (dw) | GC/MS | 50%/46% | |
| Lepoutre et al. [ | Mussels ( | Freeze-dried tissues | Trypsin in Sörensen’s phosphate buffer (pH 7.5, 37 °C) | 3 | 0.025 M | 0.025 M | 9 | NaHSO₃ + 10% H2SO4 (pH < 3) | SPE 60 mg (Waters) | n.s. | LC-MS/MS | 32.9–58.8/36.5–57% | |
Figure 3The different stages of MMPB method. These steps have been the subject of optimization work described in the following sections.
Figure 4A schematic representation of (1) the mechanism of conjugation of the Mdha7/Dha7 moiety of MCs with different thiols to create MCs-thiols derivatives as model compound for (2) deconjugation reaction with base (modified after [114]).